Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
19.14
+0.09 (0.47%)
Apr 2, 2026, 4:00 PM EDT - Market closed
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $3.54 billion as of April 2, 2026. Its market cap has decreased by -49.38% in one year.
Market Cap
3.54B
Enterprise Value
3.00B
1-Year Change
-49.38%
Ranking
Category
Stock Price
$19.14
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $3.54B, a decrease of -26.04%. That is a compound annual growth rate of -5.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 3.54B | -11.84% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 3.98B |
| Spyre Therapeutics | 3.84B |
| Crinetics Pharmaceuticals | 3.83B |
| Viking Therapeutics | 3.81B |
| ACADIA Pharmaceuticals | 3.81B |
| NewAmsterdam Pharma Company | 3.77B |
| Edgewise Therapeutics | 3.55B |
| Structure Therapeutics | 3.55B |